Supporting evidence
Gastric bypass × Fasting Plasma Glucose (FPG)
- Authoritative support
- 5
- Available studies
- 5
- Unavailable support
- 0
Available supporting studies
Study 1 · Included
Bariatric surgery enhances beta-cell function in diabetes.
Rct
- Comparison
- Subjects undergoing sleeve gastrectomy for weight loss and diabetes management. · Subjects undergoing roux en y gastric bypass for weight loss and diabetes management.
- Duration / follow-up
- 4 weeks
Relevant effects
Absolute change
0 · 0.82
Absolute change
0 · 0.82
Study 2 · Limited
Bariatric surgery improves glucose homeostasis in type 2 diabetes.
Rct
- Comparison
- Patients receiving medical therapy for type 2 diabetes. · Patients undergoing roux en y gastric bypass surgery. · Patients undergoing sleeve gastrectomy surgery.
- Duration / follow-up
- 3120 weeks
Relevant effects
Percent change
20
Percent change
20
Percent change
20
Study 3 · Included
Bariatric surgery improves insulin sensitivity in type 2 diabetes
Rct
- Comparison
- Participants undergoing roux en y gastric bypass surgery. · Participants undergoing sleeve gastrectomy surgery. · Healthy individuals without obesity and T2D serving as controls.
- Duration / follow-up
- 9 weeks
Study 4 · Included
Bariatric surgery improves type 2 diabetes remission through gut microbiota changes
Rct
- Comparison
- Participants underwent roux en y gastric bypass surgery. · Participants underwent sleeve gastrectomy surgery.
- Duration / follow-up
- 780 weeks
Relevant effects
Absolute change
1.5 · 0.046
Absolute change
1 · 0.05
Study 5 · Limited
Metabolic surgery improves incretin response in type 2 diabetes patients.
Non randomized trial
- Comparison
- Patients with class ii iii obesity and type 2 diabetes undergoing mrygb.
- Duration / follow-up
- 13 weeks
Relevant effect
Absolute change
4.61 · 0.05